Louise Hiller
University of Warwick(GB)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, Breast Lesions and Carcinomas, Advanced Breast Cancer Therapies
Most-Cited Works
- → The Warwick-Edinburgh Mental Well-being Scale (WEMWBS): development and UK validation(2007)4,935 cited
- → Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients(2014)778 cited
- → Multi-omic machine learning predictor of breast cancer therapy response(2021)600 cited
- → p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis(2003)456 cited
- → PD-L1 protein expression in breast cancer is rare, enriched in basal-like tumours and associated with infiltrating lymphocytes(2015)301 cited
- → 6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial(2019)278 cited
- → Randomised controlled study of early pulsed dye laser treatment of uncomplicated childhood haemangiomas: results of a 1-year analysis(2002)258 cited
- → Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo(2004)248 cited
- → Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers(2008)240 cited